Qternmet XR (AstraZeneca) has been FDA approved as oral adjunct treatment to diet and exercise in type 2 diabetes as adjunct in U.S. It contains dapagliflozin (SGLT2-inhibitor), saxagliptin (DPP-IV inhibitor) and metformin hydrochloride. This is an ideal combination in terms of the variety of drug mechanisms of action involved. To learn more, please click below.
Please share your thoughts and subscribe to receive my blogs.
#Qternmet XR #FDA #diabetes #treatment
Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram ReecesPiecesDI.